|
Philips Healthcare
dce-mri data processing Dce Mri Data Processing, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dce-mri+data+processing/pm40311273-69-1-6?v=Philips+Healthcare Average 90 stars, based on 1 article reviews
dce-mri data processing - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
MathWorks Inc
the processing software for all of the quantitative analyses of the data obtained by dce- and ssce-mri ![]() The Processing Software For All Of The Quantitative Analyses Of The Data Obtained By Dce And Ssce Mri, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dce-mri+data+processing/pmc03024413-174-16-20?v=MathWorks+Inc Average 90 stars, based on 1 article reviews
the processing software for all of the quantitative analyses of the data obtained by dce- and ssce-mri - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
MathWorks Inc
dce-mri data processing ![]() Dce Mri Data Processing, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dce-mri+data+processing/pmc03102848-71-0-7?v=MathWorks+Inc Average 90 stars, based on 1 article reviews
dce-mri data processing - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Journal: PLoS ONE
Article Title: Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI
doi: 10.1371/journal.pone.0016062
Figure Lengend Snippet: In vivo rVDI and rVSI maps and quantitative curves for tumor xenografts of CL1-0 cancer cells overexpressing one of three VEGF isoforms, evaluated by SSCE-MRI. Representative high-resolution maps of the (A) rVDI and (B) rVSI in the different VEGF-overexpressing and mock tumors on day 36 after tumor implantation. In rVDI map, the color ranged from blue (0 S -1/3 , lowest rVDI) to red (0.4 S -1/3 , highest rVDI). In rVSI map, the color ranged from blue (0, lowest rVSI) to red (30, highest rVSI).Quantitative analysis of (C) rVDI and (D) rVSI in the whole tumor (upper), tumor rim (middle), or tumor core (lower). Differences between VEGF-overexpressing tumors and mock tumors were significant at the * p <0.05, ** p <0.01, *** p <0.001, and **** p <0.0001 levels.
Article Snippet: The processing software for all of the quantitative analyses of the data obtained by DCE- and
Techniques: In Vivo, Tumor Implantation